Novel Epidermal Growth Factor Receptor Mutation-Specific Antibodies for Non-small Cell Lung Cancer: Immunohistochemistry as a Possible Screening Method for Epidermal Growth Factor Receptor Mutations-Reference-Cited by-同舟云学术

Novel Epidermal Growth Factor Receptor Mutation-Specific Antibodies for Non-small Cell Lung Cancer: Immunohistochemistry as a Possible Screening Method for Epidermal Growth Factor Receptor Mutations

Published:2010-10 Issue:10 Volume:5 Page:1551-1558
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Kato Yasufumi,Peled Nir,Wynes Murry W.,Yoshida Koichi,Pardo Marta,Mascaux Celine,Ohira Tatsuo,Tsuboi Masahiro,Matsubayashi Jun,Nagao Toshitaka,Ikeda Norihiko,Hirsch Fred R.

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference34 articles.

1. Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma;Mok;N Engl J Med,2009

2. Multicentre prospective phase II trial of gefitinib for advanced non-small cell lung cancer with epidermal growth factor receptor mutations: Results of the West Japan Thoracic Oncology Group trial (WJTOG0403);Tamura;Br J Cancer,2008

3. Screening for epidermal growth factor receptor mutations in lung cancer;Rosell;N Engl J Med,2009

4. Biomarker status correlates with clinical benefit: Phase 2 study of single-agent erlotinib (e) or e intercalated with carboplatin and paclitaxel (ECP) in an EGFR biomarkerselected NSCLC population;Hirsch;J Thorac Oncol,2008

5. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib;Lynch;N Engl J Med,2004

Cited by 107 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The rapidly changing field of predictive biomarkers of non-small cell lung cancer;Pathology and Oncology Research;2024-06-17

2. EPPK1 as a Prognostic Biomarker in Type I Endometrial Cancer and Its Correlation with Immune Infiltration;International Journal of General Medicine;2024-04

3. Molecular testing in lung cancer;Diagnostic Molecular Pathology;2024

4. Application of the conventional and novel methods in testing EGFR variants for NSCLC patients in the last 10 years through different regions: a systematic review;Molecular Biology Reports;2021-04

5. Extracellular Vesicle miR-200c Enhances Gefitinib Sensitivity in Heterogeneous EGFR-Mutant NSCLC;Biomedicines;2021-02-28